Singular Genomics Systems (OMIC) Revenue & Revenue Breakdown
Singular Genomics Systems Revenue Highlights
Latest Revenue (Y)
$2.91M
Latest Revenue (Q)
$442.00K
Singular Genomics Systems Revenue by Period
Singular Genomics Systems Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.91M | 280.52% |
| 2022-12-31 | $765.00K | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Singular Genomics Systems generated $2.91M in revenue during NA 2023, up 280.52% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Singular Genomics Systems Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $442.00K | -59.11% |
| 2023-12-31 | $1.08M | 133.98% |
| 2023-09-30 | $462.00K | -8.51% |
| 2023-06-30 | $505.00K | -41.48% |
| 2023-03-31 | $863.00K | 12.81% |
| 2022-12-31 | $765.00K | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Singular Genomics Systems generated $442.00K in revenue during Q1 2024, up -59.11% compared to the previous quarter, and up 57.78% compared to the same period a year ago.
Singular Genomics Systems Revenue Breakdown
Singular Genomics Systems Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Sep 23 |
|---|---|---|---|
| Consumables And Service | $700.00K | $200.00K | $200.00K |
| Instruments | - | - | $1.60M |
Singular Genomics Systems's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Consumables And Service (100.00%).
Singular Genomics Systems Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ATR | AptarGroup | $3.49B | $910.06M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
| LMAT | LeMaitre Vascular | $193.48M | $55.85M |
| NSTG | NanoString | $127.26M | $48.09M |
| PDEX | Pro-Dex | $53.84M | $14.29M |
| UTMD | Utah Medical Products | $50.22M | $10.40M |
| KRMD | KORU Medical Systems | $28.52M | $8.20M |
| POCI | Precision Optics | $21.04M | $5.24M |
| NYXH | Nyxoah | $4.30M | $1.22M |
| OMIC | Singular Genomics Systems | $2.91M | $442.00K |
| ATRI | Atrion | - | $48.77M |
OMIC Revenue FAQ
What is Singular Genomics Systems’s yearly revenue?
Singular Genomics Systems's yearly revenue for 2023 was $2.91M, representing an increase of 280.52% compared to 2022. The company's yearly revenue for 2022 was $765K, representing an increase of 100.00% compared to 2021. OMIC's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Singular Genomics Systems’s quarterly revenue?
Singular Genomics Systems's quarterly revenue for Q1 2024 was $442K, a -59.11% decrease from the previous quarter (Q4 2023), and a -48.78% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.08M, a 133.98% increase from the previous quarter (Q3 2023), and a 41.31% increase year-over-year (Q4 2022). OMIC's quarterly revenue for Q3 2023 was $462K, a -8.51% decrease from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Singular Genomics Systems’s revenue growth rate?
Singular Genomics Systems's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.